304 related articles for article (PubMed ID: 19564887)
1. Familial pituitary tumor syndromes.
Elston MS; McDonald KL; Clifton-Bligh RJ; Robinson BG
Nat Rev Endocrinol; 2009 Aug; 5(8):453-61. PubMed ID: 19564887
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility to pituitary neoplasia related to MEN-1, CDKN1B and AIP mutations: an update.
Karhu A; Aaltonen LA
Hum Mol Genet; 2007 Apr; 16 Spec No 1():R73-9. PubMed ID: 17613551
[TBL] [Abstract][Full Text] [Related]
3. Screening for genetic causes of growth hormone hypersecretion.
Rostomyan L; Beckers A
Growth Horm IGF Res; 2016; 30-31():52-57. PubMed ID: 27756606
[TBL] [Abstract][Full Text] [Related]
4. [Familial pituitary adenomas].
Burlacu MC; Tichomirowa M; Daly A; Beckers A
Presse Med; 2009 Jan; 38(1):112-6. PubMed ID: 18990538
[TBL] [Abstract][Full Text] [Related]
5. The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes.
Stratakis CA; Tichomirowa MA; Boikos S; Azevedo MF; Lodish M; Martari M; Verma S; Daly AF; Raygada M; Keil MF; Papademetriou J; Drori-Herishanu L; Horvath A; Tsang KM; Nesterova M; Franklin S; Vanbellinghen JF; Bours V; Salvatori R; Beckers A
Clin Genet; 2010 Nov; 78(5):457-63. PubMed ID: 20507346
[TBL] [Abstract][Full Text] [Related]
6. Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations.
Igreja S; Chahal HS; Akker SA; Gueorguiev M; Popovic V; Damjanovic S; Burman P; Wass JA; Quinton R; Grossman AB; Korbonits M
Clin Endocrinol (Oxf); 2009 Feb; 70(2):259-64. PubMed ID: 18710468
[TBL] [Abstract][Full Text] [Related]
7. [Genetics of familial pituitary adenomas].
Beckers A; Jaffrain-Rea ML; Daly AE
Bull Acad Natl Med; 2009 Oct; 193(7):1557-70; discussion 1570-1. PubMed ID: 20669636
[TBL] [Abstract][Full Text] [Related]
8. Frequency of familial pituitary adenoma syndromes among patients with functioning pituitary adenomas in a reference outpatient clinic.
Marques NV; Kasuki L; Coelho MC; Lima CHA; Wildemberg LE; Gadelha MR
J Endocrinol Invest; 2017 Dec; 40(12):1381-1387. PubMed ID: 28689311
[TBL] [Abstract][Full Text] [Related]
9. The clinical, pathological, and genetic features of familial isolated pituitary adenomas.
Beckers A; Daly AF
Eur J Endocrinol; 2007 Oct; 157(4):371-82. PubMed ID: 17893250
[TBL] [Abstract][Full Text] [Related]
10. Genetic mutations in sporadic pituitary adenomas--what to screen for?
Lecoq AL; Kamenický P; Guiochon-Mantel A; Chanson P
Nat Rev Endocrinol; 2015 Jan; 11(1):43-54. PubMed ID: 25350067
[TBL] [Abstract][Full Text] [Related]
11. Somatic and germline mutations in the pathogenesis of pituitary adenomas.
Vandeva S; Daly AF; Petrossians P; Zacharieva S; Beckers A
Eur J Endocrinol; 2019 Dec; 181(6):R235-R254. PubMed ID: 31658440
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone-secreting tumors: genetic aspects and data from animal models.
Lytras A; Tolis G
Neuroendocrinology; 2006; 83(3-4):166-78. PubMed ID: 17047380
[TBL] [Abstract][Full Text] [Related]
13. Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans.
Pellegata NS; Quintanilla-Martinez L; Siggelkow H; Samson E; Bink K; Höfler H; Fend F; Graw J; Atkinson MJ
Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15558-63. PubMed ID: 17030811
[TBL] [Abstract][Full Text] [Related]
14. Familial pituitary tumors.
Alband N; Korbonits M
Handb Clin Neurol; 2014; 124():339-60. PubMed ID: 25248598
[TBL] [Abstract][Full Text] [Related]
15. Clinical characterization of familial isolated pituitary adenomas.
Daly AF; Jaffrain-Rea ML; Ciccarelli A; Valdes-Socin H; Rohmer V; Tamburrano G; Borson-Chazot C; Estour B; Ciccarelli E; Brue T; Ferolla P; Emy P; Colao A; De Menis E; Lecomte P; Penfornis F; Delemer B; Bertherat J; Wémeau JL; De Herder W; Archambeaud F; Stevenaert A; Calender A; Murat A; Cavagnini F; Beckers A
J Clin Endocrinol Metab; 2006 Sep; 91(9):3316-23. PubMed ID: 16787992
[TBL] [Abstract][Full Text] [Related]
16. Cyclin-dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenoma kindreds.
Tichomirowa MA; Lee M; Barlier A; Daly AF; Marinoni I; Jaffrain-Rea ML; Naves LA; Rodien P; Rohmer V; Faucz FR; Caron P; Estour B; Lecomte P; Borson-Chazot F; Penfornis A; Yaneva M; Guitelman M; Castermans E; Verhaege C; Wémeau JL; Tabarin A; Fajardo Montañana C; Delemer B; Kerlan V; Sadoul JL; Cortet Rudelli C; Archambeaud F; Zacharieva S; Theodoropoulou M; Brue T; Enjalbert A; Bours V; Pellegata NS; Beckers A
Endocr Relat Cancer; 2012 Jun; 19(3):233-41. PubMed ID: 22291433
[TBL] [Abstract][Full Text] [Related]
17. Novel Genetic Causes of Pituitary Adenomas.
Caimari F; Korbonits M
Clin Cancer Res; 2016 Oct; 22(20):5030-5042. PubMed ID: 27742789
[TBL] [Abstract][Full Text] [Related]
18. The MENX syndrome and p27: relationships with multiple endocrine neoplasia.
Molatore S; Pellegata NS
Prog Brain Res; 2010; 182():295-320. PubMed ID: 20541671
[TBL] [Abstract][Full Text] [Related]
19. Mutation analysis of MEN1, HRPT2, CASR, CDKN1B, and AIP genes in primary hyperparathyroidism patients with features of genetic predisposition.
Vierimaa O; Villablanca A; Alimov A; Georgitsi M; Raitila A; Vahteristo P; Larsson C; Ruokonen A; Eloranta E; Ebeling TM; Ignatius J; Aaltonen LA; Leisti J; Salmela PI
J Endocrinol Invest; 2009 Jun; 32(6):512-8. PubMed ID: 19474519
[TBL] [Abstract][Full Text] [Related]
20. Familial pituitary adenomas.
Vandeva S; Vasilev V; Vroonen L; Naves L; Jaffrain-Rea ML; Daly AF; Zacharieva S; Beckers A
Ann Endocrinol (Paris); 2010 Dec; 71(6):479-85. PubMed ID: 20961530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]